Outset Medical Inc’s recently made public that its SVP Operations and R&D Nash Marc unloaded Company’s shares for reported $5093.0 on Mar 15 ’24. In the deal valued at $2.13 per share,2,391 shares were sold. As a result of this transaction, Nash Marc now holds 242,510 shares worth roughly $0.92 million.
Then, Ahmed Nabeel sold 1,584 shares, generating $4,990 in total proceeds. Upon selling the shares at $3.15, the Chief Financial Officer now owns 322,877 shares.
Before that, Trigg Leslie sold 5,320 shares. Outset Medical Inc shares valued at $18,992 were divested by the Chair and CEO at a price of $3.57 per share. As a result of the transaction, Trigg Leslie now holds 833,091 shares, worth roughly $3.16 million.
BTIG Research initiated its Outset Medical Inc [OM] rating to a Buy in a research note published on April 08, 2024; the price target was $6. A number of analysts have revised their coverage, including CL King’s analysts, who increased its forecast for the stock in early April from “a Neutral” to “a Buy”. RBC Capital Mkts also remained covering OM and has decreased its forecast on January 12, 2024 with a “Sector perform” recommendation from previously “an Outperform” rating. BofA Securities revised its rating on October 13, 2023. It rated OM as “an Underperform” which previously was an “a Buy”.
Price Performance Review of OM
On Monday, Outset Medical Inc [NASDAQ:OM] saw its stock jump 20.70% to $3.79. Over the last five days, the stock has gained 44.11%. Outset Medical Inc shares have fallen nearly -29.94% since the year began. Nevertheless, the stocks have fallen -81.91% over the past one year. While a 52-week high of $24.13 was reached on 01/03/24, a 52-week low of $1.92 was recorded on 04/15/24. SMA at 50 days reached $2.51, while 200 days put it at $6.73. A total of 16.21 million shares were traded, compared to the trading of 1.02 million shares in the previous session.
Levels Of Support And Resistance For OM Stock
The 24-hour chart illustrates a support level at 3.07, which if violated will result in even more drops to 2.35. On the upside, there is a resistance level at 4.87. A further resistance level may holdings at 5.94. The Relative Strength Index (RSI) on the 14-day chart is 77.59, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.68, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 45.61%. Stochastics %K at 81.54% indicates the stock is a selling.
The most recent change occurred on August 17, 2023 when CL King began covering the stock and recommended ‘”a Neutral”‘ rating.
